20105e9085.Wang J Qin J Li Y Cai Z Li S Zhu J et al.

This evi- dence suggests an active involvement of microbiota in the etiology andor progression of this particular kidney disease characterized by the key involvement of the immune system which is known to be importantly influenced and modulated by the microbiota .

While many recent data on the intestinal microbiota and its relationship to chronic inflammation are available for CKD patients very little is known re- garding T2DM and patients with diabetic nephropathy.

Effects of a symbiotic on gut microbiota in Mexican patients with end-stage renal disease.

Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Curr Diab Rep 2017 17 16 DOI 10.1007s11892-017-0841-zIntestinal Microbiota in Type 2 Diabetes and Chronic Kidney DiseaseAlice Sabatino1  Giuseppe Regolisti1  Carmela Cosola2  Loreto Gesualdo 2 Enrico Fiaccadori1Published online 7 March 2017 Springer ScienceBusiness Media New York 2017AbstractPurpose of the Review Diabetes mellitus is a major cause of kidney disease chronic kidney disease CKD and end- stage renal disease ESRD and are both characterized by an increased risk of cardiovascular events.

20064441027-31.Gao Z Yin J Zhang J Ward RE Martin RJ Lefevre M et al.

201667483-98.Vaziri ND Wong J Pahl M Piceno YM Yuan J DeSantis TZ et al.

Germ-free mice are resistant to obesity induced by a high-fat diet  and colonization of germ-free mice with the microbiota of obese female humans caused obesity in the colonized mouse  indicating that the composition of the microbiota can predispose to the development of obesity.

In this study glucose metabolism of germ-free mice that received the microbiota of responder subjects improved while nothing happened to germ-free mice that received the microbiota of non-responders.

